Shared metabolic shifts in endothelial cells in stroke and Alzheimer’s disease revealed by integrated analysis

• Published in: Scientific data Vol. 10; no. 1; p. 666
• Main Authors: Guo, Guangyu, Fan, Liyuan, Yan, Yingxue, Xu, Yunhao, Deng, Zhifen, Tian, Miaomiao, Geng, Yaoqi, Xia, Zongping, Xu, Yuming
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 29.09.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 631/114/2401; 692/617/375/365; Alzheimer's disease; Analysis; Cells; Datasets; Disease; Endothelial cells; Enzymes; Hemorrhage; Hospitals; Humanities and Social Sciences; Ischemia; Laboratories; Metabolic flux; Metabolic networks; Metabolism; Metabolites; multidisciplinary; Neurodegeneration; Neurodegenerative diseases; Pyruvic acid; Quality control; Risk factors; Science; Science (multidisciplinary); Stroke
• ISSN: 2052-4463; 2052-4463
• DOI: 10.1038/s41597-023-02512-5

Since metabolic dysregulation is a hallmark of both stroke and Alzheimer’s disease (AD), mining shared metabolic patterns in these diseases will help to identify their possible pathogenic mechanisms and potential intervention targets. However, a systematic integration analysis of the metabolic networks of the these diseases is still lacking. In this study, we integrated single-cell RNA sequencing datasets of ischemic stroke (IS), hemorrhagic stroke (HS) and AD models to construct metabolic flux profiles at the single-cell level. We discovered that the three disorders cause shared metabolic shifts in endothelial cells. These altered metabolic modules were mainly enriched in the transporter-related pathways and were predicted to potentially lead to a decrease in metabolites such as pyruvate and fumarate. We further found that Lef1, Elk3 and Fosl1 may be upstream transcriptional regulators causing metabolic shifts and may be possible targets for interventions that halt the course of neurodegeneration.